Loading...

Home
ETF
ARTL

ARTL

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ARTL News

Maxim Group Lowers Artelo Biosciences Rating to Hold

Nov 19 2025Benzinga

Wolfspeed Shares Surge Over 50%; Check Out 20 Stocks Making Moves in Premarket Trading

Sep 30 2025Benzinga

Artelo Biosciences Initiates Underwritten Public Offering to Secure Funding

Sep 30 2025SeekingAlpha

Artelo Biosciences Unveils Plans for Underwritten Public Offering

Sep 29 2025Yahoo Finance

Science Applications International Analyst Changes Outlook; Top 3 Downgrades for Monday Revealed

Sep 08 2025Benzinga

Artelo Biosciences Completes $3 Million Public Offering of Common Stock and Pre-Funded Warrants

Sep 05 2025NASDAQ.COM

Artelo Biosciences Completes $3.0 Million Public Offering

Sep 05 2025Newsfilter

Artelo Biosciences Sets $3 Million Price for Public Offering of Common Stock and Warrants

Sep 05 2025NASDAQ.COM

Nasdaq Rises by More Than 100 Points; Science Applications Stock Declines Following Q2 Earnings Report

Sep 04 2025Benzinga

Dow Jumps 200 Points as US Initial Jobless Claims Increase

Sep 04 2025Benzinga

Artelo Biosciences' Medication Aids Cancer Patients in Weight Recovery, Pursuing Licensing Agreement

Sep 03 2025Benzinga

Artelo Biosciences Confirms Promising Partnership Prospects for ART27.13 After Positive Interim Phase 2 CAReS Findings

Sep 03 2025Newsfilter

Artelo Biosciences Reports Encouraging Interim Phase 2 Results for Cancer Anorexia-Cachexia Syndrome (CACS) Treatment

Sep 03 2025Newsfilter

D. Boral Capital Reiterates Buy Rating for Artelo Biosciences with $18 Price Target Intact

Aug 26 2025Benzinga

Artelo Biosciences Reveals Preliminary Findings from Food Effect Study on ART26.12, an Innovative Non-Opioid Candidate for Chronic Pain Management

Aug 25 2025Newsfilter

Artelo Biosciences Announces $9.475 Million At-the-Market Private Placement to Initiate Solana Treasury Strategy, Becoming First Publicly-Traded Pharmaceutical Company to Adopt SOL as a Core Reserve Asset

Aug 04 2025Newsfilter